Testing
HIV+ Should Routinely Undergo PPD Testing
Published in AIDS Weekly, September 11th, 1995
"In adults and adolescents, reactivation tuberculosis can occur at any time during HIV infection, regardless of the CD4 lymphocyte count," researcher John P. Phair and colleagues wrote ("Quality Standard for the Identification and Treatment of Persons Coinfected with HIV and M. tuberculosis," Clinical Infectious Diseases, August 1995;21(suppl 1):S130-131).
The recommendations call for all...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1995-09-11)
More Articles from AIDS Weekly
- Commentary
AIDS Care Not Color Blind - Opportunistic Infections
CDC Says HIV+ May Need to Boil Drinking Water - Diagnostics
Monitoring CD4+ Cells Vital for Diagnosis and Care of HIV Disease - Diagnostics
New Technology for Evaluating Drug Susceptibility Needed - Disease Progression
Anti-CD8+ Response Seen in Long-Term Survivors - HIV Vaccines
Naked DNA Vaccine Moves Forward in Animal Tests - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
